Eli Lilly's new obesity pill could make weight loss easier—no needles needed
Eli Lilly's latest study shows their oral obesity pill helped people keep weight off for a full year, even after switching from injectables like Zepbound and Wegovy.
Over 300 participants took part, and those on the pill saw minimal weight regain compared to those given a placebo.
It's shaping up to be a much friendlier option for anyone tired of shots.
What's next? FDA review and market buzz
Lilly has already asked the FDA to approve the pill (called orforglipron), and it's getting fast-tracked.
While it might not beat injectables in total pounds lost, its convenience could win over a lot more users.
If approved, this daily pill could face competition from rivals like Novo Nordisk, who are expected to reach the market first with their oral options.
Full trial results are coming at an upcoming medical conference—so stay tuned!